My intent is to combine my background in microbiology and viral oncology with newer interests in cancer and herbal medicines. My objective is to initiate a productive career in research and teaching at a university or research institute that will lead to the development and clinical use of novel anticancer therapies and chemopreventive agents. The focus of this project will be mechanistic studies of herbal medicines, in particular black cohosh, on cancer in vitro and in vivo. The ideal mentor to accomplish this is Dr. I. Bernard Weinstein, who is an expert on molecular aspects of carcinogenesis and the ideal environment is Columbia University College of Physicians and Surgeons. Black cohosh, Actaea racemosa L. (= Cimicifuga racemosa), is a North American perennial in the buttercup family (Ranunculaceae) used for various women's health conditions. The overall objective of this project is to determine whether black cohosh contains components that may eventually be useful in the prevention or treatment of breast cancer. Indeed, our preliminary experiments indicate that black cohosh extracts inhibit the growth of human breast cancer cells. We will determine the pharmacokinetics of black cohosh. Partially purified extracts and specific chemicals will be examined for their effects, alone and in combination with chemotherapy agents, on the function of specific molecules that control cell growth, the cell cycle, apoptosis and the function of the ER and Her-2 receptor. Western blot analysis will be performed to examine possible effects on the expression of cyclin D1 related proteins. Luciferase reporter assays will be done to monitor effects on the transcription of NF-kB, fos, myc, jun and PPAR-g. Analytic chemical techniques will be used to identify novel compounds that might mediate these effects. To ascertain the efficacy of the compounds to treat humans, we will examine effects of an extract of black cohosh on xenografts of human breast cancer cell lines in athymic mice. This research project could identify new approaches to breast cancer prevention and therapy.

Agency
National Institute of Health (NIH)
Institute
National Center for Complementary & Alternative Medicine (NCCAM)
Type
Research Scientist Development Award - Research & Training (K01)
Project #
5K01AT001692-02
Application #
7011261
Study Section
Special Emphasis Panel (ZAT1-CP (17))
Program Officer
Sorkin, Barbara C
Project Start
2005-09-01
Project End
2008-08-31
Budget Start
2006-09-01
Budget End
2007-08-31
Support Year
2
Fiscal Year
2006
Total Cost
$100,116
Indirect Cost
Name
Columbia University (N.Y.)
Department
Physical Medicine & Rehab
Type
Schools of Medicine
DUNS #
621889815
City
New York
State
NY
Country
United States
Zip Code
10032
Einbond, Linda Saxe; Mighty, Jason; Redenti, Stephen et al. (2013) Actein induces calcium release in human breast cancer cells. Fitoterapia 91:28-38
Einbond, Linda Saxe; Soffritti, Morando; Esposti, Davide Degli et al. (2012) Pharmacological mechanisms of black cohosh in Sprague-Dawley rats. Fitoterapia 83:461-8
Einbond, Linda Saxe; Soffritti, Morando; Degli Esposti, Davide et al. (2012) Chemopreventive potential of black cohosh on breast cancer in Sprague-Dawley rats. Anticancer Res 32:21-30
Einbond, Linda Saxe; Soffritti, Morando; Esposti, Davide Degli et al. (2009) Actein activates stress- and statin-associated responses and is bioavailable in Sprague-Dawley rats. Fundam Clin Pharmacol 23:311-21
Einbond, Linda Saxe; Shimizu, Masahito; Ma, Hangbao et al. (2008) Actein inhibits the Na+-K+-ATPase and enhances the growth inhibitory effect of digitoxin on human breast cancer cells. Biochem Biophys Res Commun 375:608-13
Einbond, Linda Saxe; Wen-Cai, Ye; He, Kan et al. (2008) Growth inhibitory activity of extracts and compounds from Cimicifuga species on human breast cancer cells. Phytomedicine 15:504-11
Einbond, Linda Saxe; Su, Tao; Wu, Hsan-Au et al. (2007) Gene expression analysis of the mechanisms whereby black cohosh inhibits human breast cancer cell growth. Anticancer Res 27:697-712
Einbond, Linda Saxe; Su, Tao; Wu, Hsan-au et al. (2007) The growth inhibitory effect of actein on human breast cancer cells is associated with activation of stress response pathways. Int J Cancer 121:2073-83